13F filing recap · Q2 2023

What did Ariel Investments buy in Q2 2023?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Ariel-managed account, including accounts that belong to no fund below.

Stock value

$10.56B

Positions

116

Estimated turnover

16.4%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

MSGEMadison Square Garden Entertainment Corp.$235.24Mreported value+7.00M shares CLBCore Laboratories Inc.$223.94Mreported value+9.63M shares EDUNew Oriental Education & Technology Group Inc.$8.56Mreported value+216.7K shares IQIqiyi, Inc.$4.88Mreported value+913.8K shares CMECme Group Inc.$2.88Mreported value+15.5K shares IWSiShares Trust$206.5Kreported value+1.9K shares

Increased positions

MATMattel Inc /de/$321.75Mreported value+187.2K shares+1.1%PMPhilip Morris International Inc.$290.86Mreported value+50.8K shares+1.7%GNRCGenerac Holdings Inc.$260.87Mreported value+86.5K shares+5.2%JLLJones Lang Lasalle Incorporated$236.88Mreported value+72.3K shares

Reduced positions

BIDUBaidu, Inc.$377.36Mreported value-78.6K shares-2.8%KMTKennametal Inc$280.43Mreported value-310.1K shares-3.0%GNTXGentex Corporation$247.27Mreported value-480.8K shares-5.4%REZIResideo Technologies, Inc.$246.50Mreported value-134.6K shares

Exited positions

CLBCore Laboratories Inc.$209.68Mprior reported value-9.51M shares-100.0%CAHCardinal Health, Inc.$19.52Mprior reported value-258.6K shares-100.0%BRK.BBerkshire Hathaway Inc$4.00Mprior reported value-12.9K shares-100.0%NVSNovartis AG$805.0Kprior reported value-8.8K shares